This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Gambhir SS (2002) Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2: 683–693
Cai W et al. (2006) How molecular imaging is speeding up antiangiogenic drug development. Mol Cancer Ther 5: 2624–2633
Brooks PC et al. (1994) Requirement of vascular integrin αvβ3 for angiogenesis. Science 264: 569–571
Haubner R et al. (2001) Noninvasive imaging of αvβ3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography. Cancer Res 61: 1781–1785
Haubner R et al. (2005) Noninvasive visualization of the activated αvβ3 integrin in cancer patients by positron emission tomography and [18F]galacto-RGD. PLoS Med 2: e70
Beer AJ et al. (2006) Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin αvβ3 expression in man. Clin Cancer Res 12: 3942–3949
Chen X et al. (2004) Micro-PET imaging of αvβ3-integrin expression with 18F-labeled dimeric RGD peptide. Mol Imaging 3: 96–104
Li S et al. (2003) Imaging gastrointestinal tumours using vascular endothelial growth factor-165 (VEGF165) receptor scintigraphy. Ann Oncol 14: 1274–1277
Cai W et al. (2006) PET of vascular endothelial growth factor receptor expression. J Nucl Med 47: 2048–2056
Backer MV et al. (2007) Molecular imaging of VEGF receptors in angiogenic vasculature with single-chain VEGF-based probes. Nat Med 13: 504–509
Czernin J et al. (2006) Molecular imaging in the development of cancer therapeutics. Annu Rev Med 57: 99–118
Mulder WJ et al. (2007) Early in vivo assessment of angiostatic therapy efficacy by molecular MRI. FASEB J 21: 378–383
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Iagaru, A., Chen, X. & Gambhir, S. Molecular imaging can accelerate anti-angiogenic drug development and testing. Nat Rev Clin Oncol 4, 556–557 (2007). https://doi.org/10.1038/ncponc0929
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncponc0929
This article is cited by
-
Saving costs in cancer patient management through molecular imaging
European Journal of Nuclear Medicine and Molecular Imaging (2017)
-
Preliminary evaluation of 177Lu-labeled knottin peptides for integrin receptor-targeted radionuclide therapy
European Journal of Nuclear Medicine and Molecular Imaging (2011)
-
Microvascular endothelial cell heterogeneity: general concepts and pharmacological consequences for anti-angiogenic therapy of cancer
Cell and Tissue Research (2009)